|
1
|
Orimo H, Nakamura T, Fukunaga M, Ohta H,
Hosoi T, Uemura Y, Kuroda T, Miyakawa N, Ohashi Y and Shiraki M;
A-TOP (Adequate Treatment of Osteoporosis) research group, :
Effects of alendronate plus alfacalcidol in osteoporosis patients
with a high risk of fracture: The Japanese Osteoporosis
Intervention Trial (JOINT) − 02. Curr Med Res Opin. 27:1273–1284.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kobayashi M, Hara K and Akiyama Y: Effects
of vitamin K2 (menatetrenone) and alendronate on bone mineral
density and bone strength in rats fed a low-magnesium diet. Bone.
35:1136–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tabb MM, Sun A, Zhou C, Grün F, Errandi J,
Romero K, Pham H, Inoue S, Mallick S, Lin M, et al: Vitamin K2
regulation of bone homeostasis is mediated by the steroid and
xenobiotic receptor SXR. J Biol Chem. 278:43919–43927. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Igarashi M, Yogiashi Y, Mihara M, Takada
I, Kitagawa H and Kato S: Vitamin K induces osteoblast
differentiation through pregnane X receptor-mediated
transcriptional control of the Msx2 gene. Mol Cell Biol.
27:7947–7954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akiyama Y, Hara K, Kobayashi M, Tomiuga T
and Nakamura T: Inhibitory effect of vitamin K2 (menatetrenone) on
bone resorption in ovariectomized rats: A histomorphometric and
dual energy X-ray absorptiometric study. Jpn J Pharmacol. 80:67–74.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hara K, Akiyama Y, Nakamura T, Murota S
and Morita I: The inhibitory effect of vitamin K2 (menatetrenone)
on bone resorption may be related to its side chain. Bone.
16:179–184. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inoue T, Fujita T, Kishimoto H, Makino T,
Nakamura T, Nakamura T, Sato T and Yamazaki K: Randomized
controlled study on the prevention of osteoporotic fractures (OF
study): A phase IV clinical study of 15-mg menatetrenone capsules.
J Bone Miner Metab. 27:66–75. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Flore R, Ponziani FR, Di Rienzo TA, Zocco
MA, Flex A, Gerardino L, Lupascu A, Santoro L, Santoliquido A, Di
Stasio E, et al: Something more to say about calcium homeostasis:
The role of vitamin K2 in vascular calcification and osteoporosis.
Eur Rev Med Pharmacol Sci. 17:2433–2440. 2013.PubMed/NCBI
|
|
9
|
Zhang K, Zhang FJ, Zhao WJ, Xing GS, Bai X
and Wang Y: Effects of parathyroid hormone-related protein on
osteogenic and adipogenic differentiation of human mesenchymal stem
cells. Eur Rev Med Pharmacol Sci. 18:1610–1617. 2014.PubMed/NCBI
|
|
10
|
Rosen CJ: The role of parathyroid hormone
in the management of osteoporosis. Horm Res. 64 Suppl 2:81–85.
2005.PubMed/NCBI
|
|
11
|
Neer RM, Arnaud CD, Zanchetta JR, Prince
R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S,
Genant HK, et al: Effect of parathyroid hormone (1–34) on fractures
and bone mineral density in postmenopausal women with osteoporosis.
N Engl J Med. 344:1434–1441. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyauchi A, Matsumoto T, Sugimoto T,
Tsujimoto M, Warner MR and Nakamura T: Effects of teriparatide on
bone mineral density and bone turnover markers in Japanese subjects
with osteoporosis at high risk of fracture in a 24-month clinical
study: 12-month, randomized, placebo-controlled, double-blind and
12-month open-label phases. Bone. 47:493–502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boonen S, Marin F, Mellstrom D, Xie L,
Desaiah D, Krege JH and Rosen CJ: Safety and efficacy of
teriparatide in elderly women with established osteoporosis: Bone
anabolic therapy from a geriatric perspective. J Am Geriatr Soc.
54:782–789. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyauchi A, Matsumoto T, Shigeta H,
Tsujimoto M, Thiebaud D and Nakamura T: Effect of teriparatide on
bone mineral density and biochemical markers in Japanese women with
postmenopausal osteoporosis: A 6-month dose-response study. J Bone
Miner Metab. 26:624–634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimizu T, Takahata M, Kameda Y, Hamano H,
Ito T, Kimura-Suda H, Todoh M, Tadano S and Iwasaki N: Vitamin K-
dependent carboxylation of osteocalcin affects the efficacy of
teriparatide (PTH(1–34)) for skeletal repair. Bone. 64:95–101.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Turner RT, Van der Steenhoven JJ and Bell
NH: The effects of ovariectomy and 17 beta-estradiol on cortical
bone histomorphometry in growing rats. J Bone Miner Res. 2:115–122.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kalu DN: The ovariectomized rat model of
postmenopausal bone loss. Bone Miner. 15:175–191. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koshihara Y and Hoshi K: Vitamin K2
enhances osteocalcin accumulation in the extracellular matrix of
human osteoblast in vitro. J Bone Miner Res. 12:431 4381997.
View Article : Google Scholar
|
|
19
|
Iwasaki Y, Yamato H, Murayama H, Takahashi
T, Ezawa I, Kurokawa K and Fukagawa M: Menatetrenone prevents
osteoblast dysfunction in unilateral sciatic neurectomized rats.
Jpn J Pharmacol. 90:88–93. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hori M, Uzawa T, Morita K, Noda T,
Takahashi H and Inoue J: Effect of human parathyroid hormone
(PTH(1–34)) on experimental osteopenia of rats induced by
ovariectomy. Bone Miner. 3:193–199. 1988.PubMed/NCBI
|
|
21
|
Fox J, Miller MA, Newman MK, Metcalfe AF,
Turner CH, Recker RR and Smith SY: Daily treatment of aged
ovariectomized rats with human parathyroid hormone (1–84) for 12
months reverses bone loss and enhances trabecular and cortical bone
strength. Calcif Tissue Int. 79:262–272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iwaniec UT, Mosekilde L, Mitova-Caneva NG,
Thomsen JS and Wronski TJ: Sequential treatment with basic
fibroblast growth factor and PTH is more efficacious than treatment
with PTH alone for increasing vertebral bone mass and strength in
osteopenic ovariectomized rats. Endocrinology. 143:2515–2526. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alexander JM, Bab I, Fish S, Müller R,
Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, et
al: Human parathyroid hormone 1–34 reverses bone loss in
ovariectomized mice. J Bone Miner Res. 16:1665–1673. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matsumoto T, Miyakawa T and Yamamoto D:
Effects of vitamin K on the morphometric and material properties of
bone in the tibiae of growing rats. Metabolism. 61:407–414. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iwamoto J, Sato Y, Takeda T and Matsumoto
H: Bone quality and vitamin K2 in type 2 diabetes: Review of
preclinical and clinical studies. Nutr Rev. 69:162–167. 2011.
View Article : Google Scholar : PubMed/NCBI
|
